CA9 and lung cancer: performed genomic analysis and immunohistochemistry analysis for carbonic anhydrase IX, and demonstrated that CT treatment response biomarkers for patients with lung cancer treated with immunotherapy were strongly associated with hypoxia, a prognostic factor (56).